Literature DB >> 29545308

Full Genome Sequence of the Western Reserve Strain of Vaccinia Virus Determined by Third-Generation Sequencing.

István Prazsák1, Dóra Tombácz1, Attila Szűcs1, Béla Dénes2, Michael Snyder3, Zsolt Boldogkői4.   

Abstract

The vaccinia virus is a large, complex virus belonging to the Poxviridae family. Here, we report the complete, annotated genome sequence of the neurovirulent Western Reserve laboratory strain of this virus, which was sequenced on the Pacific Biosciences RS II and Oxford Nanopore MinION platforms.
Copyright © 2018 Prazsák et al.

Entities:  

Year:  2018        PMID: 29545308      PMCID: PMC5854772          DOI: 10.1128/genomeA.01570-17

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Poxviruses are generally brick-shaped (1), enveloped viruses that have a complex internal structure, including a relatively large double-stranded DNA genome and associated enzymes (2). In contrast to many other DNA viruses, poxviruses replicate and express their genomes within the cytoplasm rather than in the nucleus of the infected cell (3). The vaccinia virus (VV) is a historically interesting and significant virus; it has been successfully used as a vaccine for immunization against human smallpox (4–6), which was declared eradicated in 1980 by the WHO thanks to global vaccination efforts (7). The linear genome of VV is approximately 190 kb in length; it is flanked by inverted terminal repeat sequences and encodes around 220 protein-coding genes (8). The most virulent strain of VV, the Western Reserve (WR) (9), was used for our study. The currently available third-generation (long-read) sequencing platforms, namely, the Pacific Biosciences (PacBio) RS II system and the Oxford Nanopore Technologies (ONT) MinION system, were used for the cDNA sequencing. The CV-1 cell line (ATCC CCL-70) was infected with the laboratory WR strain of VV. The poly(A) fraction of the purified RNA was converted to cDNA following the Isoform Sequencing (Iso-Seq) protocol for PacBio sequencing and the cDNA-seq protocol (1D strand switching cDNA by ligation) for the MinION process. Seventeen single-molecule real-time (SMRT) cells with P6-C4 chemistry, as well as two MinION flow cells, were run on the PacBio and ONT systems, respectively. The PacBio sequencing resulted in 59,154 reads, while 16,175 reads were obtained from the MinION runs. Our data revealed extreme transcriptional activity across the entire VV genome. Both of the sequencing platforms that we used in this study cover the full-length viral DNA. The average coverages were 289.3× (PacBio) and 43.6× (ONT), and the mean sizes of the aligned read lengths were 953 bp (PacBio) and 525 bp (ONT). The PacBio raw reads were processed and mapped to the respective reference genome (GenBank accession no. NC_006998) with the BLASR long-read mapper (https://github.com/PacificBiosciences/blasr). GMAP (10) was also used for aligning the reads. The MinION sequencing reads were mapped to the reference genome by using Albacore version 1.2.6 software. The genome was assembled and the open reading frames were predicted by using Geneious software (11). The complete genome sequence of the WR strain of VV is composed of 194,888 bp. The average G+C content of the genome is 33.3%. The virus contains 218 protein-coding genes. Our data show that the sequenced WR strain differs in 163 point mutations—among which were 58 nonsilent mutations—from the GenBank reference sequence. Eighteen insertions and four deletions were also detected. The most common point mutation is a substitution of cytosine for thymidine. Most of the amino acid substitutions occurred in the C9L gene. A new coding sequence (A54L) was annotated. The majority of nucleic acid changes (21 events) were clustered in the F region of the viral genome. Mutations mainly occurred in viral genes playing a role in host defense modulation, transcription regulation, and viral replication.

Accession number(s).

The complete and annotated genome sequence of the WR strain of VV has been deposited in the European Nucleotide Archive under accession no. LT966077.
  9 in total

Review 1.  In a nutshell: structure and assembly of the vaccinia virion.

Authors:  Richard C Condit; Nissin Moussatche; Paula Traktman
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

Review 2.  Vaccinia virus vaccines: past, present and future.

Authors:  Bertram L Jacobs; Jeffrey O Langland; Karen V Kibler; Karen L Denzler; Stacy D White; Susan A Holechek; Shukmei Wong; Trung Huynh; Carole R Baskin
Journal:  Antiviral Res       Date:  2009-06-26       Impact factor: 5.970

3.  GMAP: a genomic mapping and alignment program for mRNA and EST sequences.

Authors:  Thomas D Wu; Colin K Watanabe
Journal:  Bioinformatics       Date:  2005-02-22       Impact factor: 6.937

4.  First-in-man study of western reserve strain oncolytic vaccinia virus: safety, systemic spread, and antitumor activity.

Authors:  Herbert J Zeh; Stephanie Downs-Canner; J Andrea McCart; Zong Sheng Guo; Uma N M Rao; Lekshmi Ramalingam; Stephen H Thorne; Heather L Jones; Pawel Kalinski; Eva Wieckowski; Mark E O'Malley; Manijeh Daneshmand; Kang Hu; John C Bell; Tae-Ho Hwang; Anne Moon; Caroline J Breitbach; David H Kirn; David L Bartlett
Journal:  Mol Ther       Date:  2014-10-08       Impact factor: 11.454

Review 5.  Vaccinia virus: a tool for research and vaccine development.

Authors:  B Moss
Journal:  Science       Date:  1991-06-21       Impact factor: 47.728

6.  Variola and monkeypox viruses utilize conserved mechanisms of virion motility and release that depend on abl and SRC family tyrosine kinases.

Authors:  Patrick M Reeves; Scott K Smith; Victoria A Olson; Steve H Thorne; William Bornmann; Inger K Damon; Daniel Kalman
Journal:  J Virol       Date:  2010-10-20       Impact factor: 5.103

7.  Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.

Authors:  Nir Paran; Yasemin Suezer; Shlomo Lustig; Tomer Israely; Astrid Schwantes; Sharon Melamed; Lior Katz; Thomas Preuss; Kay-Martin Hanschmann; Ulrich Kalinke; Noam Erez; Reuven Levin; Baruch Velan; Johannes Löwer; Avigdor Shafferman; Gerd Sutter
Journal:  J Infect Dis       Date:  2009-01-01       Impact factor: 5.226

8.  Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles.

Authors:  Che-Sheng Chung; Chein-Hung Chen; Ming-Yi Ho; Cheng-Yen Huang; Chung-Lin Liao; Wen Chang
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

9.  Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data.

Authors:  Matthew Kearse; Richard Moir; Amy Wilson; Steven Stones-Havas; Matthew Cheung; Shane Sturrock; Simon Buxton; Alex Cooper; Sidney Markowitz; Chris Duran; Tobias Thierer; Bruce Ashton; Peter Meintjes; Alexei Drummond
Journal:  Bioinformatics       Date:  2012-04-27       Impact factor: 6.937

  9 in total
  3 in total

1.  In Silico Repurposed Drugs against Monkeypox Virus.

Authors:  Hilbert Yuen In Lam; Jia Sheng Guan; Yuguang Mu
Journal:  Molecules       Date:  2022-08-18       Impact factor: 4.927

2.  A Sequence-Based Novel Approach for Quality Evaluation of Third-Generation Sequencing Reads.

Authors:  Wenjing Zhang; Neng Huang; Jiantao Zheng; Xingyu Liao; Jianxin Wang; Hong-Dong Li
Journal:  Genes (Basel)       Date:  2019-01-14       Impact factor: 4.096

3.  Long-read assays shed new light on the transcriptome complexity of a viral pathogen.

Authors:  Dóra Tombácz; István Prazsák; Zsolt Csabai; Norbert Moldován; Béla Dénes; Michael Snyder; Zsolt Boldogkői
Journal:  Sci Rep       Date:  2020-08-14       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.